background
Photo by Daniel H. Tong on Unsplash
News /

Newsletter: Vol 7, No. 1, March 2023

In this issue, read about a sample protocol for medication abortion with misoprostol-only as well as published research on the feasibility and acceptability of a telemedicine medication abortion service adapted for a setting with compulsory waiting periods. Also, read about early findings from our MA-ASAP pilot study, the Misoprostol or Oxytocin for Labour Induction research dissemination event in India and approval of mifepristone in Argentina.

Read the full Newsletter.